EverGlade, a national advisory firm that helps innovators navigate the federal funding ecosystem, successfully supported Landmark Bio through negotiations to secure up to $18.3 million in funding. The ...
The non-small cell lung cancer clinical trial analysis report delivers important insights into ongoing research of 120+ ...
In this conference report from ABRF 2026, the authors reflect on the meeting's insights into core facility research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results